The first Denali Therapeutics trade was made in Q2 2019.
Since then Jim Simons bought shares eleven more times and sold shares on ten occasions. The investor completely sold their stake between Q3 2025 and Q1 2026.
Avg closing price
Price range
Sold -10.7k shares
Q1 2026
Avg closing price
$20.18
Price range
$16.02
-
$22.74
Sold 82.1% shares (-49.1k shares)
Q4 2025
Avg closing price
$16.92
Price range
$14.41
-
$20.11
Sold 69.4% shares (-136k shares)
Q3 2025
Avg closing price
$14.39
Price range
$12.75
-
$15.65
Increased shares by 13.1% (+22.6k shares)
Q2 2025
Avg closing price
$14.05
Price range
$11.47
-
$16.65
New holding (+173k shares)
Q1 2025
Avg closing price
$19.27
Price range
$13.60
-
$23.59
Sold -162k shares
Q1 2024
Avg closing price
$18.79
Price range
$15.83
-
$23.35
Sold 65.4% shares (-306k shares)
Q4 2023
Avg closing price
$19.81
Price range
$16.20
-
$23.18
Increased shares by 0.0% (+51 shares)
Q3 2023
Avg closing price
$25.37
Price range
$20.63
-
$30.17
Increased shares by 14.6% (+59.7k shares)
Q2 2023
Avg closing price
$28.12
Price range
$23.37
-
$32.96
Increased shares by 63.5% (+159k shares)
Q1 2023
Avg closing price
$27.52
Price range
$21.91
-
$32.67
Sold 36.4% shares (-143k shares)
Q4 2022
Avg closing price
$29.75
Price range
$26.28
-
$33.92
Increased shares by 54.7% (+139k shares)
Q3 2022
Avg closing price
$32.51
Price range
$25.97
-
$38.53
Increased shares by 106.8% (+131k shares)
Q2 2022
Avg closing price
$26.20
Price range
$20.88
-
$35.19
Increased shares by 125.8% (+68.3k shares)
Q1 2022
Avg closing price
$34.41
Price range
$29.00
-
$47.27
Sold 43.2% shares (-41.3k shares)
Q4 2021
Avg closing price
$47.38
Price range
$42.59
-
$55.02
Increased shares by 731.3% (+84.1k shares)
Q3 2021